Public Pension Fund Group et al v. KV Pharmaceutical Company et al

  1. March 20, 2014

    KV Pharma Reaches $12.8M Deal To Settle Shareholder Action

    KV Pharmaceutical Co. and the lead plaintiffs in a securities class action alleging the drugmaker hid U.S. Food and Drug Administration violations to inflate its share price have reached a $12.8 million settlement agreement that, if approved, would end more than five years of litigation, according to a filing in Missouri federal court Wednesday.

  2. May 01, 2013

    KV Pharma Can't Duck Securities Suit Over FDA Woes

    A Missouri federal judge refused Tuesday to dismiss a proposed class action against KV Pharmaceutical Co., ruling that top officials likely knew that company reports failed to disclose U.S. Food and Drug Administration regulatory violations and that investors were harmed by plummeting stock prices once the truth was revealed.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!